Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Ascorbic acid 50mg tablets
0906031C0AAAFAF
|
Ascorbic acid | Ascorbic acid | Nutrition and Blood | 5,638 |
|
Calcium acetate 950mg tablets
0905022C0AAAEAE
|
Calcium acetate | Calcium acetate | Nutrition and Blood | 5,638 |
|
Flucloxacillin 125mg/5ml oral solution sugar free
0501012G0AAAPAP
|
Flucloxacillin sodium | Flucloxacillin sodium | Infections | 5,632 |
|
Nicorette QuickMist 1mg/dose mouthspray freshmint
0410020B0BBAZBW
|
Nicorette | Nicotine | Central Nervous System | 5,627 |
|
Zimovane 7.5mg tablets
0401010Z0BBAAAA
|
Zimovane | Zopiclone | Central Nervous System | 5,627 |
|
Libra all slc cath + pfs of purified water for inflation & empty syrg for deflation male 12Ch-24Ch
21020001458
|
Libra all slc cath + pfs of purified water for inflation & empty syrg for deflation male 12Ch-24Ch | Catheters | Appliances | 5,626 |
|
Nifedipine 60mg modified-release capsules
0206020R0AABFBF
|
Nifedipine | Nifedipine | Cardiovascular System | 5,626 |
|
Oxypro 15mg modified-release tablets
0407020ADBSACAS
|
Oxypro | Oxycodone hydrochloride | Central Nervous System | 5,615 |
|
Efexor XL 75mg capsules
0403040W0BBADAD
|
Efexor | Venlafaxine | Central Nervous System | 5,606 |
|
Brava adhesive remover wipes
23151001504
|
Brava adhesive remover wipes | Adhesive Removers (Sprays/Liquids/Wipes) | Stoma Appliances | 5,603 |
|
Irbesartan 300mg / Hydrochlorothiazide 12.5mg tablets
0205052A0AAABAB
|
Irbesartan/hydchlorothiazide | Irbesartan with diuretic | Cardiovascular System | 5,600 |
|
Pregabalin 25mg tablets
0408010AEAAASAS
|
Pregabalin | Pregabalin | Central Nervous System | 5,595 |
|
Mesalazine 800mg gastro-resistant tablets
0105010B0AAASAS
|
Mesalazine | Mesalazine (Systemic) | Gastro-Intestinal System | 5,589 |
|
Lumecare Carbomer 0.2% eye gel
21300000700
|
Lumecare Carbomer 0.2% eye gel | Eye Products | Appliances | 5,583 |
|
Zetuvit Plus Superabsorber dressing 10cm x 10cm
20031700307
|
Zetuvit Plus Superabsorber dressing 10cm x 10cm | Wound Management & Other Dressings | Dressings | 5,580 |
|
Tirzepatide 10mg/0.6ml inj 2.4ml pf dispos dev
0601023AZAAAFAF
|
Tirzepatide | Tirzepatide | Endocrine System | 5,564 |
|
Adapt CeraRing barrier ring 48mm x 2.3mm
23850108515
|
Adapt CeraRing barrier ring 48mm x 2.3mm | Skin Protectors | Stoma Appliances | 5,562 |
|
Vitalograph peak flow meter standard range (43602)
21120000145
|
Vitalograph peak flow meter standard range (43602) | Peak Flow Meters | Appliances | 5,561 |
|
Brivaracetam 25mg tablets
0408010ALAAABAB
|
Brivaracetam | Brivaracetam | Central Nervous System | 5,555 |
|
Enerzair Breezhaler 114microg / 46microg / 136microg/dose
0302000W0BBAAAA
|
Enerzair | Mometasone/glycopyrronium/indacaterol | Respiratory System | 5,554 |
|
Venlalic XL 150mg tablets
0403040W0BNABAK
|
Venlalic | Venlafaxine | Central Nervous System | 5,549 |
|
Doxylamine 10mg / Pyridoxine 10mg gastro-resistant tablets
0406000AAAAABAB
|
Doxylamine succinate/pyridoxine hydrochloride | Doxylamine succinate/pyridoxine hydrochloride | Central Nervous System | 5,547 |
|
NovoPen Echo Plus hypodermic insulin inj pen reusable for 3ml cart 0.5unit dialup/range 0.5-30u blue
21012600161
|
NovoPen Echo Plus hypodermic insulin inj pen reusable for 3ml cart 0.5unit dialup/range 0.5-30u blue | Other Appliances | Appliances | 5,546 |
|
Buccastem M 3mg tablets
0406000T0BFAAAK
|
Buccastem M | Prochlorperazine maleate | Central Nervous System | 5,540 |
|
Zetuvit Plus Superabsorber dressing 10cm x 20cm
20031700308
|
Zetuvit Plus Superabsorber dressing 10cm x 20cm | Wound Management & Other Dressings | Dressings | 5,540 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.